EP2044025
Kínólínónafleiður og lyfjasamsetningar þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.7.2007EP published:
3.10.2012EP application number:
07819899.1
EP translation filed:
28.11.2012Grant published:
15.12.2012EPO information:
European Patent Register
Max expiry date:
1.7.2027Expiry date:
1.7.2026Next due date:
31.7.2026
Title:
QUINOLINONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS
Timeline
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
LOHSE, OlivierAddress:
Basel, CH
Name:
MONNIER, StéphanieAddress:
Raedersheim, FR
Name:
REBER, Jean-LouisAddress:
Kembs, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0613156Date:
30.6.2006Country:
GB
Number:
0613158Date:
30.6.2006Country:
GB
Number:
0613159Date:
30.6.2006Country:
GB
Number:
0613160Date:
30.6.2006Country:
GB
Number:
06117129Date:
13.7.2006Country:
EP
Classification
Categories:
C07D 215/26, A61K 31/4704, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.6.2013
Expires: 1.7.2014
Payer: Árnason Faktor
Number: 8
Paid: 10.6.2014
Expires: 1.7.2015
Payer: Árnason Faktor
Number: 9
Paid: 9.6.2015
Expires: 1.7.2016
Payer: Árnason Faktor
Number: 10
Paid: 8.6.2016
Expires: 1.7.2017
Payer: Árnason Faktor
Number: 11
Paid: 26.6.2017
Expires: 1.7.2018
Payer: Árnason Faktor
Number: 12
Paid: 27.6.2018
Expires: 1.7.2019
Payer: Árnason Faktor
Number: 13
Paid: 25.6.2019
Expires: 1.7.2020
Payer: Árnason Faktor
Number: 14
Paid: 25.6.2020
Expires: 1.7.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.6.2021
Expires: 1.7.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.6.2022
Expires: 1.7.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 28.6.2023
Expires: 1.7.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.6.2024
Expires: 1.7.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 4.7.2025
Expires: 1.7.2026
Payer: Árnason Faktor ehf.